BiotechTubeBiotechTube
Home/Whitehawk Therapeutics/CBO Placeholder
CP

CBO Placeholder

Chief Business Officer

Whitehawk Therapeutics

Therapeutic Areas

OncologyImmuno-Oncology

Whitehawk Therapeutics Pipeline

DrugIndicationPhase
WHK-001Advanced Solid Tumors (including Recurrent Glioblastoma and NSCLC)Phase 1/2

Leadership Team at Whitehawk Therapeutics

CP
CEO Placeholder
Chief Executive Officer
CP
CSO Placeholder
Chief Scientific Officer
CP
CMO Placeholder
Chief Medical Officer
VR
VP Research Placeholder
Vice President of Research
View full Whitehawk Therapeutics profile